KLK3 and Familial prostate cancer: To circumvent the requirement of purifying phage lysates or individual TAA protein, we have focused on targeted identification of B cell epitopes from TAA [18], and developed a novel multiplex assay platform that quantifies autoAb plus total PSA in a single reaction for prostate cancer.